Molecular Mechanism of HSV Entry and Spread
Molecular Mechanism of HSV Entry and Spread
批准号:
7878408
负责人:
DEEPAK SHUKLA
金额:
$1.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-14 至 2010-10-31
关键词:
BindingBinding SitesBiochemicalBiological AssayBiological ProcessBlindnessCapsidCell fusionCell membraneCellsComplexCytoplasmDataEventGlycoproteinsGoalsHealthHeparan Sulfate ProteoglycanHeparitin SulfateHerpesvirus 1HumanImmunocompromised HostIn VitroIndividualInfectionInorganic SulfatesLaboratoriesLesionLifeMediatingModelingMolecularMorbidity - disease rateNeuronsPenetrationPeptidesPhage DisplayPlaguePopulationPrimary Cell CulturesProtein IsoformsProteinsReagentRecurrenceResearchRiskRoleScreening procedureSimplexvirusSiteSmall Interfering RNATechnologyTissuesUnspecified or Sulfate Ion SulfatesVariantViralVirionVirusVirus DiseasesVirus Receptorsbasein vivomutantneonatenovelprotein expressionreceptorreceptor bindingsimplexvirus receptorsulfotransferasetissue tropismvirus envelopevirus host interaction
中文摘要
描述(由申请人提供):该项目的长期目标是确定单纯疱疹病毒(HSV)入侵人类细胞并将病毒传播到神经元组织的分子基础。单纯疱疹病毒感染是世界范围内的一个主要健康问题,感染着世界上60%-90%的人口,其中许多人一生中都受到初发和复发皮损的困扰。此外,新生儿中单纯疱疹病毒病的发病率和致盲风险,甚至新生儿和越来越多的免疫功能受损个体中的致死风险。3-O-硫酸乙酰肝素(3-OS HS)通过提供包膜糖蛋白D(GD1)的结合位点,作为HSV-1的特异性进入受体。最近的一些数据表明,3-OS HS可以通过介导细胞融合来介导所有形式的原发感染,从HSV-1进入细胞到病毒在细胞之间的传播。细胞间的融合以及病毒包膜与宿主细胞膜的融合似乎需要Gd/3-OS HS复合体与另外三种病毒糖蛋白Gb、Gh和Gl结合。目前尚不清楚受体结合如何触发导致融合的一系列事件。将对GD1(野生型和突变型)、GD2和3-OS HS变体进行广泛的研究,以更好地了解GD和3-OS HS之间产生相互作用的结构和生化要求。将使用多种检测方法,包括体外和体内3-OS HS与GD的结合、细胞融合和病毒进入。此外,为了确定3-OS HS在HSV-1进入中的意义,将在一些自然靶细胞中进行研究,以检测3-OS HS的表达及其在组织趋向性中的潜在贡献。这些研究将通过使用原代细胞培养、蛋白质表达分析、噬菌体展示筛选产生的新肽和siRNA(小干扰RNA)技术来辅助。该试剂还可用于评价3-OS HS的其他生物学功能。
英文摘要
DESCRIPTION (provided by the applicant): The long-term goal of this project is to determine the molecular basis of herpes simplex virus (HSV) invasion of human cells and spread of the virus to neuronal tissues. HSV infection is a major health problem worldwide infecting 60-90% of the world's population, many of which are plagued by initial and recurrent lesions for their entire lives. Adding to that is the morbidity and the risk of blindness from ocular lesions and even lethality of HSV disease in neonates and in increasing number of immunocompromised individuals. The 3-O-sulfated heparan sulfate (3-OS HS) serves as a specific entry receptor for HSV type-1 by offering binding sites for envelope glycoprotein D (gD1). Some recent data suggests that 3-OS HS can mediate all forms of primary infection, from HSV-1 entry into cells to cell-to-cell spread of the virus by mediating cell fusion. The cell-to-cell fusion as well as the fusion of the viral envelope with host cell membrane appear to require gD/3-OS HS complex in concert with three additional viral glycoproteins, gB, gH and gL. It is not clear how the receptor binding triggers the sequence of events that result in fusion. Extensive studies involving gD1 (wild-type and mutant forms), gD2, and 3-OS HS variants will be performed to develop a better understanding of the structural and biochemical requirements for a productive interaction between gD and 3-OS HS. Multiple assays that include in vitro and in vivo binding of 3-OS HS with gD, cell fusion, and viral entry will be used. Further, to determine the significance of 3-OS HS in HSV-1 entry, studies will be performed in some natural target cells to examine expression and the potential contribution of 3-OS HS in tissue tropism. These studies will be aided by the use of primary cell cultures, protein expression assays, novel peptides generated by phage display screening, and siRNA (small-interfering RNA) technology. The reagents generated would also be useful for evaluating other biological functions of 3-OS HS as well.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s12250-008-2992-1
发表时间:
2008-12-01
期刊:
VIROLOGICA SINICA
影响因子:
5.5
作者:
[O'Donnell, Christopher D, Shukla, Deepak]
通讯作者:
Shukla, Deepak
DOI:
10.2174/1874357901307010041
发表时间:
2013-01-01
期刊:
The open virology journal
影响因子:
--
作者:
[Choudhary, Samiksha, Burnham, Lorrie, Tiwari, Vaibhav]
通讯作者:
Tiwari, Vaibhav
DOI:
10.2174/1874357901307010005
发表时间:
2013
期刊:
The open virology journal
影响因子:
--
作者:
[Baldwin J, Shukla D, Tiwari V]
通讯作者:
Tiwari V
DOI:
10.1093/glycob/cws106
发表时间:
2012-11
期刊:
Glycobiology
影响因子:
4.3
作者:
[V. Tiwari;Erika Maus;I. Sigar;K. H. Ramsey;D. Shukla]
通讯作者:
V. Tiwari;Erika Maus;I. Sigar;K. H. Ramsey;D. Shukla
HPSE in Ocular Herpes Infection
-
批准号:10242774
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
HPSE in Ocular Herpes Infection
-
批准号:10475706
-
项目类别:
-
资助金额:$38.78万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A small molecule inhibitor of HSV genital infections
-
批准号:10205994
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A small molecule inhibitor of HSV genital infections
-
批准号:9763444
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
HPSE in Ocular Herpes Infection
-
批准号:9761531
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
HPSE in Ocular Herpes Infection
-
批准号:10753834
-
项目类别:
-
资助金额:$42.28万
-
财政年份:2018
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:10557908
-
项目类别:
-
资助金额:$47.61万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:8962978
-
项目类别:
-
资助金额:$39.95万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:10363614
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
A new molecular therapy against ocular herpes
-
批准号:9313256
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2015
-
负责人:DEEPAK SHUKLA
-
依托单位:
Novel Peptides Against Modified Heparan Sulfate
-
批准号:8917086
-
项目类别:
-
资助金额:$19.3万
-
财政年份:2014
-
负责人:DEEPAK SHUKLA
-
依托单位:
Novel Peptides Against Modified Heparan Sulfate
-
批准号:8702500
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2014
-
负责人:DEEPAK SHUKLA
-
依托单位:
Role of Optineurin in Ocular Herpes Infection
-
批准号:8430175
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2013
-
负责人:DEEPAK SHUKLA
-
依托单位:
Micro-nano Platforms for HSV Vaccine
-
批准号:8430071
-
项目类别:
-
资助金额:$23.93万
-
财政年份:2013
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8510554
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8106157
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:7932799
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:8304258
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Significance of heparan sulfate in HSV-1 spread
-
批准号:7639893
-
项目类别:
-
资助金额:$10.62万
-
财政年份:2009
-
负责人:DEEPAK SHUKLA
-
依托单位:
Molecular Mechanism of HSV Entry and Spread
-
批准号:7342886
-
项目类别:
-
资助金额:$28.45万
-
财政年份:2005
-
负责人:DEEPAK SHUKLA
-
依托单位:
海外基金